INCELL

Innovative Life Science Solutions™

Menu
  • Home
    • Contact
    • Close
  • Products
    • My Account
    • Close
  • Reg Med
    • Registrations Licenses & Certifications
    • Cell & Tissue Products
      • Regenerative & Stem Cells
      • Tissue-Derived Products
      • Reagents & Testing
      • INCELL Established Cell Lines
    • Tissue Collections & Kit Products
    • Storage of Cell & Tissue Products
    • Services: Manufacturing , Testing and R&D
      • Accelerated Product Development Services
      • Regenerative & Stem Cell Products
    • Close
  • Micro
    • Microbiology & Vaccine Products
      • Microbiology Testing
        • Sterility: GMP and USP Compliant
        • Microbial Bioburden
        • Endotoxin/Pyrogen Testing
        • Mycoplasma Testing
        • Antimicrobial & Microbiological Testing
        • Antimicrobials: New Product Testing In Vivo
    • Vaccines and Microbiology Products
      • Innovative Platforms, Tools and Vaccines
      • Microbiology & Vaccines Collaborations
    • Clinical Studies
    • Close
  • Clinical
    • Clinical Trials
    • Personalized Medicine
    • Close
  • About
    • Corporate
      • History
      • Mission
      • Registration, Licenses & Certificates
      • Memberships, Boards and Committees
    • Organization & Management
      • Board Members
        • Executive Managers
      • Key Alliances
        • Collaborative Business Model
    • Business Units & Activities
      • Regenerative Medicine
      • Media, Solutions & Kits
      • Microbiology & Vaccine Products
      • 503B Compounding & Formulation
    • Close
  • News
    • Close

Author Archives: INCELL Online Team

INCELL to Expand Manufacturing

Published on: February 24, 2016 | Author: INCELL Online Team
INCELL

February 24, 2016-San Antonio, TX USA. READY TO GROW! INCELL received a new Certificate of Occupancy from the City of San Antonio for its adjacent building expansion space of about 10,000 additional square feet at 12746 Cimarron Path, Suite 103. Updating and renovations will commence March 1, 2016. INCELL affiliated companies 4RMED (focused on clinical […]

INCELL Spotlights Research Integrity

Published on: February 23, 2016 | Author: INCELL Online Team
incell_man_UTSA

February 23, 2016-San Antonio, TX USA. Dr. Mary Pat Moyer, INCELL CEO and Chief Science Officer, and UTHSCSA Professor gave an invited presentation “Managing Integrity as a Core Value in a Biomedical Company” at the University of Texas Health Science Center at San Antonio “Spotlight on Research Integrity” Lecture Series. More Information…

Culture Media

Published on: January 26, 2016 | Author: INCELL Online Team

  General Description Table 1 shows media designations and supplement options. M3ä Base Medium is a proprietary formula that is a serum-free, highly enriched liquid culture medium for human stem cells and other progenitor and fastidious cell types. It is also useful for culture of animal-derived stem and progenitor cells, tumor cells, and tissues.  It […]

Follow Us

Recent Posts

  • Dr. Mary Pat Moyer inducted to the National Academy of Engineering for her contribution to regenerative medicine, October 2019
  • Dr. Moyer Addresses Orthopedic Physicians at AAOM National Meeting
  • INCELL Global Expansion
  • INCELL Sponsors WSCS in December 2016
  • Dr. Mary Pat Moyer: Luminary Woman of San Antonio

Contact INCELL Corporation LLC

12734 Cimarron Path (Directions)
San Antonio, Texas 78249
Tel: 210-877-0100|Toll-free: 800.364.1765
Fax: 210-877-0200

Privacy | Contact

Copyright © 2021. All Rights Reserved.

Designed by WebAuthorings.